Moreover, Rac1 and its effectors have important roles in cardiomyocyte electrophysiology and arrhythmogenesis and therapeutic approaches directly targeting Rac1, NOX2, PAK1, or apoptosis signal-regulating kinase 1 (ASK1) have shown promise in preclinical models of cardiac disease. Here, MAP3K5 is linked to heart disorder.